Risk of Esophageal Adenocarcinoma Decreases With Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization-Reference-Cited by-同舟云学术

Risk of Esophageal Adenocarcinoma Decreases With Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization

Published:2014-10 Issue:10 Volume:12 Page:1667-1676.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Thrift Aaron P.,Risch Harvey A.,Onstad Lynn,Shaheen Nicholas J.,Casson Alan G.,Bernstein Leslie,Corley Douglas A.,Levine David M.,Chow Wong–Ho,Reid Brian J.,Romero Yvonne,Hardie Laura J.,Liu Geoffrey,Wu Anna H.,Bird Nigel C.,Gammon Marilie D.,Ye Weimin,Whiteman David C.,Vaughan Thomas L.

Funder

National Institutes of Health

National Health and Medical Research Council of Australia

National Institute of Health Career Development

Australian Research Council

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends;Thrift;Ann Oncol,2012

2. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005;Cook;Br J Cancer,2009